AzTrials
AzTrials

Cervical Spondylosis With MyelopathyNCT01868958

DTI of the Brain and Cervical Spine: Evaluation in Normal Subjects and Patients With Cervical Spondylotic Myelopathy

An observational study of Cervical Spondylosis With Myelopathy, run by Emory University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

More than half of the middle-aged population has radiologic evidence of cervical spondylosis (Irvine 1965) and a subset of this population develops cervical spondylotic myelopathy (CSM), a condition in which the spinal cord is impaired, either by direct mechanical compression or indirectly by arterial deprivation… Read more about this study

Who is it for?
Ages 30 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Cervical Spondylosis With Myelopathy
How many people
26 participants
Where
1 siteUnited States
Study dates
Jan 2013to Jun 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients at the Emory Orthopaedics \& Spine Center suffering signs and symptoms of cervical myelopathy and with evidence of radiographic cervical cord compression with or without abnormal spinal cord signal intensity secondary to spondylosis.

Who may be able to join

  • 20 patients will be selected by an experienced team of orthopedic specialist from the Emory Orthopaedics \& Spine Center and will include patients suffering signs and symptoms of cervical myelopathy and with evidence of radiographic cervical cord compression with or without abnormal spinal cord signal intensity secondary to spondylosis.
  • 20 controls : Aged matched to the patient group. No history of CSM.

Who cannot join

  • Any history of significant trauma implicating the brain or cervical spine, including prior motor vehicle collision and history of prior brain, neck or cervical spine surgery.
  • Any history of neurological disease
  • Dental braces or similar orthodontic devices.
  • Claustrophobia

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Center for Systems Imaging (CSI), Emory University

    Atlanta, Georgia, 30329

Other trials in United States

About this study

Official title: Diffusion Tensor Imaging of the Brain and Cervical Spine: Evaluation of Reproducibility in Normal Subjects and Diagnostic Utility in Patients With Cervical Spondylotic Myelopathy

More than half of the middle-aged population has radiologic evidence of cervical spondylosis (Irvine 1965) and a subset of this population develops cervical spondylotic myelopathy (CSM), a condition in which the spinal cord is impaired, either by direct mechanical compression or indirectly by arterial deprivation and/or venous stasis. In this study we aim to test the hypothesis that diffusion tensor imaging can provide prognostic information on the integrity of the spine in these patients which is unavailable from conventional MRI images

Read the detailed description

More than half of the middle-aged population has radiologic evidence of cervical spondylosis and a subset of this population develops cervical spondylotic myelopathy (CSM), a condition in which the spinal cord is impaired, either by direct mechanical compression or indirectly by arterial deprivation and/or venous stasis. Although many operations are performed for conditions related to CSM, no consensus exists regarding the timing of the surgical intervention or how to select among the available surgical options for a given patient. Many factors have been implicated in the propensity for CSM to develop including advanced age, disability at presentation, cord diameter, cord area, altered cord signal on MRI (T2- and T1- weighted images), increased cervical spinal mobility and a congenitally narrow spinal canal. The same factors may also determine the response to surgery, either positively (increased cervical mobility) or negatively (advanced age, congenitally narrow spinal canal). The potential complications of surgical procedures are noteworthy. Although incapacitating adverse effects are uncommon, their occurrence in a disease process with a potentially benign course is of undoubted gravity. Finally, it should be noted that the radiologic criteria of cervical root or cord compression on MRI are subjective and it is uncertain that they correlate with the clinical symptoms.

Diffusion tensor imaging (DTI) is sensitive to the motion of water and is considered to be a marker for axonal integrity in the brain. There has been much interest in applying the technique to the spine and in particular to the evaluation of patients with CSM. In the brain DTI is performed using a single shot echo planar imaging (SS-EPI) sequence which acquires all of the data for a single slice following the application of a single excitation pulse and diffusion gradients. While very efficient in terms of data collections there are several problems with SS-EPI, notably that 1) It is best suited to the acquisition of relatively small imaging matrices, resulting in either low spatial resolution or the use of additional techniques to reduce the field of view (FOV). Increasing the number of echoes acquired to increase the resolution does not produce an increase in the acquired resolution since the decay of the signal during the longer echo train results in increased blurring of the image. 2) The images are distorted by susceptibility gradients in areas close to the interfaces between tissue and bone or osseous structures. These factors have made applying DTI to clinical studies of the spine problematic. Specifically:-

  1. The small size of the spinal cord means that high spatial resolution is required.
  2. The susceptibility effects from the surrounding osseous structure result in image distortion.
  3. The motion of the cord during the cardiac cycle leads to artifacts.

Readout segmented EPI (RESOLVE or RS-EPI) sequence has been shown to be capable of obtaining images with higher spatial resolution and reduced distortion in the brain. We have recently demonstrated that the RESOLVE sequence can also be used to obtain high quality DTI images of the cervical spine of volunteers (see figure 1) and can provide clinically useful information in subjects with metastases in the spine. The RESOLVE sequence breaks the data collection into several segments, resulting in reduced distortion and the potential to obtain images with higher resolution, but at the cost of either increased scan time or a reduced number of directions for the diffusion gradients (i.e. reduced signal to noise ratio (SNR)). The RESOLVE sequence also incorporates real-time assessment of the data, enabling data corrupted by motion to be rejected and then reacquired. We now wish to optimize, and assess the clinical utility of, the RESOLVE sequence in patients with CSM by applying it to a group of CSM patients and a group of aged matched control subjects. The raw diffusion images are post-processed to yield parametric images which characterize the diffusivity (mean, longitudinal and radial) and anisotropy (directional dependence) of the diffusion. The anisotropy of the diffusion data is typically quantified using the fractional anisotropy (FA) index, however, we have recently shown that two other quantities, the mode and ellipsoidal area ratio (EAR) of the diffusion tensor, provide useful supplementary information and we propose to use all three parameters when analyzing the anisotropy of the diffusion data from this study.

Using the RESOLVE sequence address these first two of the "bullet" points listed above and we found that in some subjects high quality DTI images of the spine can be obtained without the use of cardiac gating, however, for a robust clinical sequence we, and other groups, have found cardiac gating to be essential. Another issue to consider for DTI studies of the spine is the orientation of the scan. Sagittal images provide coverage of the whole spine with relatively few slices, which is particularly beneficial when cardiac gating is employed. Axial slices have the advantage that the changes in the configuration of the spine in the caudal-cranial direction are relatively slow, meaning that thicker slices can be used without a significant loss of information. However, a relatively large number of slices are still required to cover the entire C-spine resulting in a lengthy measurement time when cardiac gating is used.

Objectives The investigators wish to try and answer the following questions for the C-spine:-

  1. What are the diffusion characteristic of the normal C-spine (spatial variation and age dependence)?
  2. How do the RESOLVE and SS-EPI images of the spine compare in terms of image quality?
  3. What is the effect of changing the number of segments for the RESOLVE sequence?
  4. When comparing SS-EPI and RESOLVE are there statistically significant differences in the derived values of anisotropy or diffusivity?
  5. Are the diffusion characteristics of the C-spine of subjects with CSM significantly different from those of aged matched controls?
  6. Can DTI of the spine be used to derive diagnostic information, either in terms of prognostic information for individual CSM patients or the identification of sub-groups of CSM patients? For the brain the question we would be addressing are:-
  7. When comparing SS-EPI and RESOLVE are there statistically significant differences in the derived values of anisotropy or diffusivity? 2) Is there a statistically significant difference in the volume of the fiber tracts derived using the two sequences or between the two groups? 3) Is the diffusion data from the brains of patients with CSM significantly different from that of the controls?
Keywords
Magnetic resonance imaging (MRI), Diffusion tensor imaging, Spine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01868958
Study groupRoleWhat they receive
CSM subjectsSubjects with clinical indications of cervical spondylotic myelopathy (CSM).
Control groupAged matched to the CSM group but with no signs of CSM

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diffusion properties of the spinal cord

    Two parameters characterizing the diffusion of water in the spinal cord will be studied.

    1. The fractional anisotropy reflects the orientational motion of water and the average value will be assessed over the length of the cervical spine for both the control and patient groups. This quantity has no units.
    2. The trace of the diffusion tensor. This measures the mean diffusivity of the water in the spinal cord and is measured in m^2/sec.

    Measured: The diffusion properties are measured in a single imaging session lasting approximately 50 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionJun 2015
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01868958
Sponsor's protocol ID
IRB00058267
Status last verified
Jul 2015
First submitted
13 May 2013
Last updated
15 Jul 2015
Results posted
No
Data monitoring committee
No

Publications

  • Hayes LL, Jones RA, Palasis S, Aguilera D, Porter DA. Drop metastases to the pediatric spine revealed with diffusion-weighted MR imaging. Pediatr Radiol. 2012 Aug;42(8):1009-13. doi: 10.1007/s00247-011-2295-9. Epub 2011 Nov 4.

    PubMed 22052343

Questions about this trial

What is this clinical trial studying?

An observational study of Cervical Spondylosis With Myelopathy, run by Emory University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diffusion properties of the spinal cord (time frame: The diffusion properties are measured in a single imaging session lasting approximately 50 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01868958, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2015; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in